These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3722875)

  • 1. From the National Institute of Allergy and Infectious Diseases. Summary of the 21st United States-Japan Joint Cholera Conference.
    Edelman R; Sack RB
    J Infect Dis; 1986 Aug; 154(2):377-80. PubMed ID: 3722875
    [No Abstract]   [Full Text] [Related]  

  • 2. From the National Institute of Allergy and Infectious Diseases. Summary of the 19th United States-Japan Joint Cholera Conference.
    Edelman R; Pierce NF
    J Infect Dis; 1984 Jun; 149(6):1014-7. PubMed ID: 6376650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of the 27th United States-Japan Joint Conference on Cholera and Related Diarrheal Diseases.
    Spriggs DR; Guerrant RL
    J Infect Dis; 1993 Jan; 167(1):1-6. PubMed ID: 8093361
    [No Abstract]   [Full Text] [Related]  

  • 4. Summary of the 29th United States-Japan joint Conference on Cholera and Related Diarrheal Diseases.
    Lang DR; Guerrant RL
    J Infect Dis; 1995 Jan; 171(1):8-12. PubMed ID: 7798685
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-O1 Vibrio cholerae and epidemic cholera.
    Commun Dis Rep CDR Wkly; 1993 Jun; 3(24):107. PubMed ID: 7693194
    [No Abstract]   [Full Text] [Related]  

  • 6. From the National Institute of Allergy and Infectious Diseases. Summary of the 25th United States-Japan Joint Conference on cholera and related diarrheal diseases.
    Spriggs DR; Sack RB
    J Infect Dis; 1990 Sep; 162(3):584-90. PubMed ID: 2201739
    [No Abstract]   [Full Text] [Related]  

  • 7. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.
    Albert MJ; Alam K; Rahman AS; Huda S; Sack RB
    J Infect Dis; 1994 Mar; 169(3):709-10. PubMed ID: 8158063
    [No Abstract]   [Full Text] [Related]  

  • 9. Lessons from cholera & Vibrio cholerae.
    Ghose AC
    Indian J Med Res; 2011 Feb; 133(2):164-70. PubMed ID: 21415490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular characterization of Vibrio cholerae O139 isolates from Asia.
    Echeverria P; Hoge CW; Bodhidatta L; Serichantalergs O; Dalsgaard A; Eampokalap B; Perrault J; Pazzaglia G; O'Hanley P; English C
    Am J Trop Med Hyg; 1995 Feb; 52(2):124-7. PubMed ID: 7872438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea.
    Sánchez J; Holmgren J
    Curr Opin Immunol; 2005 Aug; 17(4):388-98. PubMed ID: 15963708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States.
    Crump JA; Bopp CA; Greene KD; Kubota KA; Middendorf RL; Wells JG; Mintz ED
    J Infect Dis; 2003 Mar; 187(5):866-8. PubMed ID: 12599062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibrio cholerae and cholera: out of the water and into the host.
    Reidl J; Klose KE
    FEMS Microbiol Rev; 2002 Jun; 26(2):125-39. PubMed ID: 12069878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype.
    Waldor MK; Mekalanos JJ
    J Infect Dis; 1994 Aug; 170(2):278-83. PubMed ID: 8035010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins.
    Satchell KJ
    Microbes Infect; 2003 Nov; 5(13):1241-7. PubMed ID: 14623020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.
    Gupta SS; Bharati K; Sur D; Khera A; Ganguly NK; Nair GB
    Indian J Med Res; 2016 May; 143(5):545-51. PubMed ID: 27487997
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell wall antigens in Vibrio cholerae O139 Bengal, a causative agent of new epidemics.
    Weintraub A; Jansson PE; Jansson M; Paredes L; Hultenby K; Widmalm G; Albert MJ
    Prog Clin Biol Res; 1995; 392():141-50. PubMed ID: 8524919
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmid-induced loss of virulence in Vibrio cholerae.
    Sinha VB; Srivastava BS
    Nature; 1978 Dec; 276(5689):708-9. PubMed ID: 732874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.